Ralph S. Baric

From Wikipedia, the free encyclopedia

Jump to navigation Jump to search

Ralph S. Baric
Born	1954 (age 66–67)
Nationality	American
Alma mater	North Carolina State University
Scientific career
Fields	Epidemiology
Institutions	University of North Carolina at Chapel Hill
Thesis	Inhibitors of host transcription block Sindbis virus replication (1982)
Doctoral advisor	Robert E. Johnston

Ralph Steven Baric (born 1954) is William R. Kenan Jr. Distinguished Professor in the Department of Epidemiology, and Professor in the Department of Microbiology and Immunology at the The University of North Carolina at Chapel Hill.

Baric's work involves coronaviruses, including gain of function research aimed at devising effective vaccines against coronaviruses.^[1] Baric has warned of emerging coronaviruses presenting as a significant threat to global health, due to zoonosis.^[2][3]

Career

Baric has published multiple articles and book chapters on the epidemiology and genetics of various viruses, including norovirus,^[4][5][6] and coronaviruses,^[7][8] as well as potential treatments for viral diseases.^[9][10]

In 2015, with Shi Zhengli of the Wuhan Institute of Virology, he published an article titled "A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence," which describes their work in generating and characterizing "a chimeric virus expressing the spike of bat coronavirus SHC014 in a mouse-adapted SARS-CoV backbone."^[11]

In 2020, Baric contributed to establishing the official nomenclature and taxonomic classification of SARS-CoV-2.^[12]

References

1. 
   

12. "The species Severe acute respiratory syndrome-related coronavirus : classifying 2019-nCoV and naming it SARS-CoV-2". Nature Microbiology. Retrieved 2021-02-13.

External links

Wikiquote has quotations related to: Ralph S. Baric

• Ralph S. Baric, PhD

"Hear from top scientist who has spent 'years' working toward a cure for coronaviruses". Msnbc.com. Retrieved 2021-02-13.

Schmidt, Charles (2020-06-09). "For Experts Who Study Coronaviruses, a Grim Vindication". Medscape. Retrieved 2021-02-13.

Rowan Jacobsen, 29 June 2021. Inside the risky bat-virus engineering that links America to Wuhan. MIT Technology Review.

"Human susceptibility and resistance to Norwalk virus infection". Nature Medicine. 2003-04-14. Retrieved 2021-02-13.

Teunis, Peter F.M.; Moe, Christine L.; Liu, Pengbo; E. Miller, Sara; Lindesmith, Lisa; Baric, Ralph S.; Le Pendu, Jacques; Calderon, Rebecca L. (2008). "Norwalk virus: How infectious is it?". Journal of Medical Virology. Wiley. 80 (8): 1468–1476. doi:10.1002/jmv.21237. ISSN 0146-6615. PMID 18551613. S2CID 35718373.

Lindesmith, Lisa C.; Donaldson, Eric F.; Lobue, Anna D.; Cannon, Jennifer L.; Zheng, Du-Ping; Vinje, Jan; Baric, Ralph S. (2008-02-12). "Mechanisms of GII.4 Norovirus Persistence in Human Populations". PLOS Medicine. Journals.plos.org. 5 (2): e31. doi:10.1371/journal.pmed.0050031. PMC 2235898. PMID 18271619. Retrieved 2021-02-13.

"A decade after SARS: strategies for controlling emerging coronaviruses". Nature Reviews Microbiology. 2013-11-11. Retrieved 2021-02-13.

Brian, D. A.; Baric, R. S. (2005). "Coronavirus Genome Structure and Replication". Current Topics in Microbiology and Immunology. Berlin, Heidelberg: Springer Berlin Heidelberg. pp. 1–30. doi:10.1007/3-540-26765-4_1. ISBN 978-3-540-21494-6. ISSN 0070-217X. PMID 15609507. S2CID 20502390.

"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV". Nature Communications. 2020-01-10. Retrieved 2021-02-13.

Sheahan, Timothy P.; Sims, Amy C.; Graham, Rachel L.; Menachery, Vineet D.; Gralinski, Lisa E.; Case, James B.; Leist, Sarah R.; Pyrc, Krzysztof; Feng, Joy Y.; Trantcheva, Iva; Bannister, Roy; Park, Yeojin; Babusis, Darius; Clarke, Michael O.; Mackman, Richard L.; Spahn, Jamie E.; Palmiotti, Christopher A.; Siegel, Dustin; Ray, Adrian S.; Cihlar, Tomas; Jordan, Robert; Denison, Mark R.; Baric, Ralph S. (2017-06-28). "Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses". Science Translational Medicine. 9 (396): eaal3653. doi:10.1126/scitranslmed.aal3653. ISSN 1946-6234. PMC 5567817. PMID 28659436.

"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence". Nature Medicine. Retrieved 2021-02-13.